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1. Introduction 
Bacitracin synthetase is an enzyme complex [ 1,2] 
composed of three complementary fractions called A, 
B and C [3] (see fig.1). F’hosphopantetheine which is 
covalently bound to the fractions [2,3,.5] is probably 
involved in the biosynthesis of bacitracin. Similar to 
gramicidin S and tyrocidine [6] its mechanism of 
synthesis has been described as a thiotemplate mecha- 
nism [7]. In the present work the bacitracin synthetase 
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Fig.l. Schematic representation of bacitracin synthetase. 
A, B, and C represent the three complementary enzymes of 
bacitracin synthetase. The activation sites of the constituent 
amino acids (numbered 1-12 from the N-terminal end) in 
bacitracin, are indicated on the figure. The zig-zag line 
illustrates covalently linked phosphopantetheine. 
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production has been investigated. When Bacillus 
licheniformis was growl1 in the defined medium M 20, 
bacitracin was produced during growth [8]. It was 
shown that the three enzymes A, B and C of bacitracin 
synthetase occurred simultaneously for a short time 
early in the growth phase. The bacitracin synthetase 
harvested at this stage was able to produce bacitracin 
for more than one hour and at least 38% of the radio- 
active substrate amino acid could be incorporated 
into bacitracin. Later in the growth phase, bacitracin 
synthetase seemed to associate with the membranes 
or cell walls. Furthermore, it was shown that the level 
of bacitracin synthetase which was found in the cells 
did not correspond to the titer of bacitracin in different 
media. 
2. Methods and materials 
2.1. Growth of B. licheniformis 
Spores (about 2 X 10’) of B. licheniformis ATCC 
10716 were suspended in 200 ml medium M 20 [8]. 
pH was adjusted to 6.0 with NaOH. After incubation 
in a New Brunswick rotary shaker (16 h, 37°C) the 
culture was used to inoculate 8 litres of medium M 20 
(pH 6) in a New Brunswick fermentor. 
The cells were grown at 37°C with stirring (500 
rev/min and aeration (8 litres air/min). The cells were 
harvested early in the growth phase Assonm 1.2 in a 1 
cm cell in Spectronic 20 spectrophotometer) and 
washed with 0.04 M potassium phosphate buffer, pH 
7.2, containing 2 mM MgS04 and then stored at -20°C. 
2.2. Bacitracin synthetase 
Frozen cells were thawed and lyzed with the aid of 
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lysozyme, and a 43-49% satd. (NH,) aSO4 fraction 
was prepared as previously described [2]. 
2.3. Fractionation of bacitracin synthetase 
Bacitracin synthetase was fractionated into three 
complementary enzymes A, B and C on a 3, 3’-diamino- 
dipropylamine-Sepharose column [3,7]. 
2.4. Estimation of bacitracin synthesis 
The reaction mixture was modified from that 
previously used [2]. It contained 2 I.tmol ATP, 1 pmol 
MnCl, (the pH of the solution of ATP and MnCl, was 
adjusted to 7.4 with KOH), 5 prnol potassium phosphate 
buffer, pH 7.4, 0.1 pmol dithiotreitol, 0.02 pmol of 
all the Lforms of the amino acids in bacitracin except 
one which was 14C-labelled (0.1 &i, 0.01 pmol) and 
enzyme solution in a final volume of 0.1 ml. The mix- 
ture was incubated for 30 min at 37°C and bacitracin 
was isolated and identified as described [2]. 
2.5. Estimation of ATP-[32P]PPi exchange reaction 
The incubations were carried out at 37°C for 30 
min and the exchange reaction was determined as 
described [2]. 
2.6. Labelled substances a measurement of radioactivity 
L-[U-14C]Isoleucine and Na432P20, were obtained 
from New England Nuclear Corp., Boston and from 
The Radiochemical Centre, Amersham. For counting 
a Packard Tri-Carb Liquid Scintillation counter or a 
Frieseke and Hoepfner gas-flow counter was used. 
3. Results 
3.1. The time of harvest 
In the medium M 20 bacitracin was produced during 
growth [8]. The bacitracin synthetase activity occurred 
early in the growth phase (tig.2). An enzyme fraction 
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Fig. 2. Bacitracin production and bacitracin synthetase activity in relation to bacterial growth in medium M 20. The culture was 
grown as described in the experimental section. At intervals 20 ml aliquots were withdrawn. The absorbance (o) of the culture was 
measured, the bacitracin content (A) was determined microbiologically and the bacitracin synthesizing activity in the 55% satd. 
(NH,),SO, fraction (0) and in the pellet fraction (+) were assayed as described. The total amount of radioactivity in each incubation 
mixture was 110 000 cpm. 
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Fig.3. Bacitracin synthesizing activities in different enzyme 
preparates. Bacitracin synthesis was measured as described in 
43-49% satd. (NH,),SO, fractions (10 ~1) isolated from cells 
(20 ml), grown as previously described [ 21 (o), at A,,,3.0 and 
from cells grown in medium M 20 (o), at A,,,1.2. The total 
amount of radioactivity in each incubation mixture wgs 
104 000 cpm. 
prepared at this stage of growth seemed to be free 
(or partially free) of proteolytical activities since the 
addition of paramethylsulfonylfluorid, an inhibitor of 
proteolytical activities, did not stimulate bacitracin 
production (results not shown). The enzyme fraction 
was able to produce bacitracin for more than one hour. 
Of the labelled amino acid (L-isoleucine) 12% was 
incorporated into bacitracin. When the concentration 
of L-isoleucine was 0.01 mM, 38% of it was incor- 
porated into bacitracin. In fig.3 the synthetase activity, 
as a function of time, of this enzyme preparate and 
that previously used [2] are compared. A three-fold 
increase of the time of synthesis was obtained by the 
new procedure. 
Bacitracin synthetase occurs for only a short period 
during growth (fig.2). The onset of synthesis of the 
individual enzymes of the enzyme complex seems to 
occur simultaneously. This was shown by isolating baci- 
tracin synthetase at different stages of growth. The 
presence of the enzymes A, Band C was shown by mea- 
suring the [32P]PP1-ATPexchange reaction in the 
presence of specific amino acids [2] after alkyl-Sepha- 
rose chromatography [3] (results not shown). 
Table 1 
Effect of manganese on the production of bacitracin and 
bacitracin synthetase 
MnSO,.H,O 
(mg/litre) 
0 
0.2 
10 
Bacitracin 
produced 
during 16 h 
W/ml) 
1.5 
15 
40 
Level of 
bacitracin 
synthetase 
(cpm) 
12 500 
19 000 
18 500 
The culture was grown as described in medium M 20 (which 
contains 10 mg MnSO,.H,O/litre and at reduced manganese 
concentrations. Bacitracin was assayed microbiologically and 
the maximum level of bacitracin synthetase was measured as 
described under fig.2 
3.2. Dependence of manganese 
The production of bacitracin in the medium was 
strongly dependent on the concentration of manganese. 
When zero, 0.2 or 10 mg MnS04.H20/litre medium was 
used, 1.5, 15 and 40 IU bacitracin/ml were obtained 
(see table 1). However, this does not correspond to 
the production of bacitracin synthetase. In the three 
experiments the level of cell-free bacitracin synthetase 
activity was almost the same. 
3.3. Pellet-bonded bacitracin synthetase 
The cell free (soluble) bacitracin synthetase activity 
was lost during growth ((n--n) fig.2). The activities 
of the complementary enzymes A, B and C disappeared 
simultaneousely as shown by the [32P]PPi-ATP 
exchange reaction [2] (results not shown). However, 
in vivo bacitracin production still occurred later in the 
growth period. At this stage of growth the bacitracin 
synthetase activity seemed to be tightly associated 
with the cell fragments ( (t--t) fig.2). Repeated 
lysozyme treatment did not release the synthetase 
into solution. The drop in soluble plus pellet-bonded 
activities (not drawn on fig.2) between the two activity 
peaks on fig.2 is probably due to proteolytical activities 
and/or the unsuitable incubation conditions at lower 
synthetase concentrations. 
4. Discussion 
The bacitracin production seems not to reflect the 
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level of bacitracin synthetase in different media. A 
control mechanism of bacitracin synthetase is probably 
involved. 
It has been reported that peptide synthe tases includ- 
ing bacitracin synthetase, only appear in the late 
growth phase [2,6]. The rapid destruction or inacti- 
vation of the enzyme complexes, after having reached 
their maximum activity peak is probably due to the 
presence of proteolytical enzymes [9] which appear 
at this time of growth in most bacilli. In the medium 
M 20 bacitracin was produced during growth [8] and 
bacitracin synthetase was isolated at an early stage. As 
far as we know, this is the first example of a peptide 
antibiotic synthetase which is isolated in the early 
growth phase. The absence of proteolytical activities 
probably made it possible to obtain a prolonged baci- 
tracin production in vitro. For further studies on the 
biosynthesis of bacitracin this condition for cell 
harvest will be preferred. 
The detection of bacitracin synthetase early in the 
growth phase and the formation of bacitracin during 
growth indicate a function of bacitracin during cell 
multiplication and not in the sporulation process as 
reported for gramicidines and tyrocidines [lo]. The 
isolation and characterization of a defect bacitracin 
synthetase of a zero-producer of bacitracin which 
sporulates normally [7,1 l] suports this view. 
The soluble bacitracin becomes predominately cell 
bound later in the growth phase. This does not seem 
to have any negative effect on bacitracin formation, 
and may represent a natural immobilization of an 
enzyme complex which probably protects it against 
increasing proteolytical activities. 
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